MAIA Biotechnology, Inc. (MAIA)
NYSEAMERICAN: MAIA · Real-Time Price · USD
1.320
+0.010 (0.76%)
May 13, 2026, 10:54 AM EDT - Market open
MAIA Biotechnology Employees
MAIA Biotechnology had 13 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
13
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,865,274
Market Cap
80.09M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 13 | 0 | - |
| Dec 31, 2024 | 13 | 0 | - |
| Dec 31, 2023 | 13 | -5 | -27.78% |
| Dec 31, 2022 | 18 | 9 | 100.00% |
| Dec 31, 2021 | 9 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| TScan Therapeutics | 142 |
| XBiotech | 85 |
| Fortress Biotech | 78 |
| Acrivon Therapeutics | 76 |
| PolyPid | 75 |
| Pliant Therapeutics | 49 |
| eXoZymes | 32 |
MAIA News
- 5 weeks ago - MAIA Biotechnology secures funding for clinical trial of ateganosine - TheFly
- 5 weeks ago - MAIA Biotechnology Expects Recent $33 Million Capital Raise to Fully Fund Ongoing Pivotal Phase 3 Trial of Novel Telomere-Targeting Anticancer Therapy - GlobeNewsWire
- 6 weeks ago - MAIA Biotechnology Reports Overall Survival Exceeding Two Years for Eight Patients in Ongoing Phase 2 Clinical Trial in Non-Small Cell Lung Cancer - GlobeNewsWire
- 6 weeks ago - Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA) - GlobeNewsWire
- 2 months ago - MAIA Biotechnology Announces Closing of $30 Million Underwritten Public Offering of Common Stock - GlobeNewsWire
- 2 months ago - MAIA Biotechnology 20M share Spot Secondary priced at $1.50 - TheFly
- 2 months ago - MAIA Biotechnology announces common stock offering, no amount given - TheFly
- 2 months ago - MAIA Biotechnology Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire